Dentists in Paris, IL Accepting Medicare
5 Dentists found. Showing 1 - 5
 Mr. Robert Ellsworth Sprague, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 110 Sheriff St, Paris, IL 61944 Phone: 217-466-3465 |
Dr. Jeffrey David Staley-henne, D.M.D. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 701 S Main St, Paris, IL 61944 Phone: 217-463-4155 Fax: 217-463-4156 |
Dr. John Henry Wright, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 524 E Madison St, Paris, IL 61944 Phone: 217-463-4110 Fax: 217-463-3144 |
Dr. Jason Allen Graham, D.M.D Dentist Medicare: Medicare Enrolled Practice Location: 1113 N Main St, Paris, IL 61944 Phone: 217-465-4321 Fax: 217-463-1729 |
Dr. Zachary Tyler Ferguson, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 522 E Jasper St, Paris, IL 61944 Phone: 217-466-3090 |
News Archive
Hospitals can make patients sick, reveals Consumer Reports
Hospitals are thought to be sterile, safe environments where sick people get better, not sicker. But that's not always the case according to a new investigation by Consumer Reports into hospital-acquired infections.
'Don't litigate, innovate.' How to implement a fully funded alternative to the new health care overhaul – and it's already in the law
In his latest Kaiser Health News column, Robert Laszewski writes: "What if a Republican governor and a Republican legislature had the ability to implement their version of health insurance reform and the federal government would have to pay for it? It's a great idea.
ACADIA and BLS enter agreement to conclude pimavanserin collaboration
ACADIA Pharmaceuticals Inc. today announced that it has entered into an agreement with Biovail Laboratories International SRL ("BLS"), a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc., pursuant to which ACADIA and BLS have agreed to conclude their previously established collaboration to develop and commercialize pimavanserin in the United States and Canada.
Study finds link between maternal-fetal deaths and day, month of delivery
In a study to be presented Friday, Jan. 27, in the oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting, researchers with the Baylor College of Medicine in Houston, Texas, presented the study titled Association between day and month of delivery with maternal-fetal mortality: weekend effect and July phenomenon in current obstetric practice.
Dexmedetomidine may be an effective treatment option for opioid-induced hyperalgesia
Surgical patients who demonstrated heightened pain sensitivity, or hyperalgesia, induced by high doses of a synthetic opioid had their symptoms alleviated by co-treatment with dexmedetomidine, according to new research. Study investigators, who presented their results today at the 29th Annual Meeting of the American Academy of Pain Medicine, concluded that dexmedetomidine may be a new and effective treatment option for opioid-induced hyperalgesia (OIH).
› Verified 4 days ago
Counselors
Pharmacists
Clinical Social Workers
Dentists
Occupational Therapists
Psychologists